Loading organizations...
§ Private Profile · Boston, MA, USA
Pharmaceutical company enhancing medication delivery for ocular safety.
TearClear has raised $26.5M across 2 funding rounds.
TearClear has raised $26.5M in total across 2 funding rounds.
TearClear has raised $26.5M in total across 2 funding rounds.
TearClear's investors include Bluestem Capital, Falcon Vision, Flying L Partners, Visionary Ventures, Visionary Ventures Fund.
TearClear has raised $26.5M across 2 funding rounds. Most recently, it raised $22.0M Series B in August 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 12, 2020 | $22M Series B | — | Bluestem Capital, Falcon Vision, Flying L Partners, Visionary Ventures | Announced |
| May 31, 2017 | $4.5M Series A | Bluestem Capital, Visionary Ventures Fund | — | Announced |